O'Rahilly S
University of Cambridge, Department of Medicine, Addenbrooke's, Hospital.
BMJ. 1997 Mar 29;314(7085):955-9. doi: 10.1136/bmj.314.7085.955.
A massive increase in the global prevalence of non-insulin dependent diabetes is likely to occur as "Westernisation" of dietary habits and patterns of physical activity becomes more widespread. Advances in molecular and cellular science may provide some useful insights and therapeutic tools to assist in the fight against the severe consequences of this epidemic. These will include the better identification of specific aetiological subtypes of the disease; the identification of new drugs through the better understanding of the biology of insulin secretion and action; and the targeting of therapies to specific subtypes of the disease. In addition, knowledge of the precise mode of action and antidiabetes drugs may facilitate the design of more effective non-pharmacological manipulations; the genetic identification of "high risk" asymptomatic people may allow us to target screening and preventive strategies more effectively; and investigations into the mechanisms that underlie the link between low birth weight and later diabetes should provide new routes towards treatment and prevention. Barriers to the implementation of the global measures required to stem the predicted flood of non-insulin dependent diabetes may prove insuperable, but if we are to have any success, then close collaboration between clinicians, epidemiologists, public health physicians, and laboratory scientists will be essential.
随着饮食习惯和体育活动模式的“西方化”日益普遍,全球非胰岛素依赖型糖尿病的患病率可能会大幅上升。分子和细胞科学的进展可能会提供一些有用的见解和治疗工具,以帮助应对这一流行病的严重后果。这些包括更好地识别该疾病的特定病因亚型;通过更好地理解胰岛素分泌和作用的生物学机制来识别新药;以及针对该疾病的特定亚型进行治疗。此外,了解抗糖尿病药物的确切作用方式可能有助于设计更有效的非药物干预措施;对“高风险”无症状人群的基因识别可能使我们能够更有效地针对筛查和预防策略;对低出生体重与后期糖尿病之间联系的潜在机制进行调查,应该会为治疗和预防提供新途径。实施遏制预计将大量出现的非胰岛素依赖型糖尿病所需的全球措施的障碍可能难以克服,但如果我们要取得任何成功,临床医生、流行病学家、公共卫生医生和实验室科学家之间的密切合作将至关重要。